Page 43 - Программа - Всероссийский конгресс с международным участием «Нейронауки: интеграция теории и практики», 18-19 ноября 2022 года, Онлайн
P. 43

Russian Military Medical
                 ORIGINAL ARTICLES                          Vol. 41 (4) 2022                          Academy Reports
           392

                10. Kopaeva MY, Alchinova IB, Cherepov AB, et al. New Properties of   a cross-laboratory study. Physiol Genomics. 2008;34(3):243–255.
                a Well-Known Antioxidant: Pleiotropic Effects of Human Lactoferrin   DOI: 10.1152/physiolgenomics.90207.2008
                in Mice Exposed to Gamma Irradiation in a Sublethal Dose. Antioxi-  17. Carola V, D’Olimpio F, Brunamonti E, Mangia F, Renzi P. Evalua-
                dants (Basel). 2022; 11(9):1833. DOI: 10.3390/antiox11091833  tion of the elevated plus-maze and open-field tests for the assess-
                11. Kopaeva MY, Cherepov AB, Nesterenko MV, Zarayska-  ment of anxiety-related behaviour in inbred mice. Behav Brain Res.
                ya  IY. Pretreatment with Human Lactoferrin Had a Positive Ef-  2002;134(1–2):49–57. DOI: 10.1016/s0166-4328(01)00452-1
                fect on the Dynamics of Mouse Nigrostriatal System Recov-  18. Ferger B, Teismann P, Earl CD, Kuschinsky K, Oertel WH. The
                ery after Acute MPTP Exposure.  Biology  (Basel). 2021;10(1):24.  protective effects of PBN against MPTP toxicity are independent of
                DOI: 10.3390/biology10010024                      hydroxyl radical trapping.  Pharmacol Biochem Behav. 2000;65(3):
                12. Faucheux BA, Nillesse N, Damier P, et al. Expression of lacto-  425–431. DOI: 10.1016/s0091-3057(99)00229-4
                ferrin receptors is increased in the mesencephalon of patients with   19. Xu SF, Zhang YH, Wang S, et al. Lactoferrin ameliorates dopami-
                Parkinson disease. Proc Natl Acad Sci USA. 1995;92(21):9603–9607.   nergic neurodegeneration and motor deficits in MPTP-treated mice.
                DOI: 10.1073/pnas.92.21.9603                      Redox Biol. 2019;21:101090. DOI: 10.1016/j.redox.2018.101090
                13. Fillebeen C, Descamps L, Dehouck MP, et al. Receptor-mediated   20. Liu H, Wu H, Zhu N, et al. Lactoferrin protects against iron
                transcytosis of lactoferrin through the blood-brain barrier.  J Biol   dysregulation, oxidative stress, and apoptosis in 1-methyl-4-phe-
                Chem. 1999;274(11):7011–7017. DOI: 10.1074/jbc.274.11.7011  nyl-1,2,3,6-tetrahydropyridine (MPTP)-induced Parkinson’s disease
                14. Suzuki YA, Lopez V, Lönnerdal B. Mammalian lactoferrin recep-  in mice. J Neurochem. 2020;152(3):397–415. DOI: 10.1111/jnc.14857
                tors: structure and function. Cell Mol Life Sci. 2005;62(22):2560–2575.   21. Rousseau E, Michel PP, Hirsch EC. The iron-binding protein lac-
                DOI: 10.1007/s00018-005-5371-1                    toferrin protects vulnerable dopamine neurons from degeneration
                15. Rosa AI, Duarte-Silva S, Silva-Fernandes A, et al. Taurourso-  by preserving mitochondrial calcium homeostasis. Mol Pharmacol.
                deoxycholic Acid Improves Motor Symptoms in a Mouse Model   2013;84(6):888–898. DOI: 10.1124/mol.113.087965
                of Parkinson’s Disease.  Mol Neurobiol. 2018;55(12):9139–9155.   22. Kopaeva MY, Azieva AM, Cherepov AB, et al. Human lactoferrin
                DOI: 10.1007/s12035-018-1062-4                    enhances the expression of transcription factor c-Fos in neuronal
                16. Mandillo S, Tucci V, Hölter SM, et al. Reliability, robust-  cultures under stimulated conditions.  Patogenez  [Pathogenesis].
                ness, and reproducibility in mouse behavioral phenotyping:   2021;19(1):74–78. (In Russ.) DOI: 10.25557/2310-0435.2021.01.74-78





















                ОБ АВТОРАХ                                        AUTHORS' INFO

                *Марина Юрьевна Копаева, научный сотрудник;       *Marina Yu. Kopaeva, Researcher;
                адрес: 123181, Россия, г. Москва, пл. Академика Курчатова, д. 1;   address: 1, Akademika Kurchatova sq., 123182, Moscow;
                ORCID: https://orcid.org/0000-0002-6100-2830;     ORCID: https://orcid.org/0000-0002-6100-2830;
                Scopus Author ID: 57211437591; eLibrary SPIN: 1480-6220;  Scopus Author ID: 57211437591; eLibrary SPIN: 1480-6220;
                Author ID: 819255; Researcher ID: AAE-3285-2020;  Author ID: 819255; Researcher ID: AAE-3285-2020;
                e-mail: m.kopaeva@mail.ru                         e-mail: m.kopaeva@mail.ru
                Антон Борисович Черепов, ведущий инженер;         Anton B. Cherepov, M.D., Lead Engineer;
                ORCID: https://orcid.org/0000-0002-3757-5292;     ORCID: https://orcid.org/0000-0002-3757-5292;
                Scopus Author ID: 6507318449; eLibrary SPIN: 1465-2380;  Scopus Author ID: 6507318449; eLibrary SPIN: 1465-2380;
                Author ID: 95260; Researcher ID: D-8053-2014;     Author ID: 95260; Researcher ID: D-8053-2014;
                e-mail: ipmagus@mail.ru                           e-mail: ipmagus@mail.ru
                Ирина Юрьевна Зарайская, канд. биол. наук;        Irina Yu. Zarayskaya, Ph.D. (Biology);
                ORCID: https://orcid.org/0000-0003-2371-0227;     ORCID: https://orcid.org/0000-0003-2371-0227;
                Scopus Author ID: 55389409800; eLibrary SPIN: 6858-2891;  Scopus Author ID: 55389409800; eLibrary SPIN: 6858-2891;
                Author ID: 129628; e-mail: irzar2003@mail.ru      Author ID: 129628; e-mail: irzar2003@mail.ru

                * Автор, ответственный за переписку / Corresponding author
                                                    DOI: https://doi.org/10.17816/rmmar111944
   38   39   40   41   42   43   44   45   46   47   48